Navigation Links
Discovery of a new means to erase pain
Date:7/9/2014

Qubec City, July 9, 2014 A study published in the scientific journal Nature Neuroscience by Yves De Koninck and Robert Bonin, two researchers at Universit Laval, reveals that it is possible to relieve pain hypersensitivity using a new method that involves rekindling pain so that it can subsequently be erased. This discovery could lead to novel means to alleviate chronic pain.

The researchers from the Faculty of Medicine at Universit Laval and Institut universitaire en sant mentale de Qubec (IUSMQ) were inspired by previous work on memory conducted some fifteen years ago. These studies had revealed that when a memory is reactivated during recall, its neurochemical encoding is temporarily unlocked. Simultaneous administration of a drug that blocks neurochemical reconsolidation of the memory results in its erasure.

The investigators wanted to see whether a similar mechanism was at play during neurochemical encoding of pain sensitization. To this end, they injected capsaicin in the foot of mice. Capsaicin, the pungent chemical in chili pepper, triggers a burning sensation. The procedure, which causes no physical damage, triggers pain hypersensitivity through a process of protein synthesis in the spinal cord. After capsaicin injections, the mechanical pressure at which mice would flinch was about a third of that in the normal situation.

Three hours later, the researchers administered a second dose of capsaicin and, at the same time, a drug that blocks protein synthesis. The hypersensitivity then vanished rapidly. Within less than 2 hours, the pressure tolerated by the mice was back to 70% of normal.

Yves De Koninck explains that "when the protein synthesis inhibitor is administered alone, the hypersensitivity remains. The second injection of capsaicin is necessary to render the sensitivity to pain unstable and be able to interfere with its neurochemical reconsolidation. The challenge now will be to find protein synthesis inhibitors that are nontoxic and cause minimal side effects in humans".

Yves De Koninck is a professor of psychiatry and neuroscience at Universit Laval and scientific director of the Institut universitaire en sant mentale de Qubec. Robert Bonin is a postdoctoral fellow in Professor De Koninck's laboratory, where he works on the mechanisms underlying the etiology of chronic pain. He is the recipient of a Catherine Bushnell Fellowship from the Louise and Alan Edwards Foundation. The work was supported financially by the Canadian Institutes of Health Research and the Fonds de la recherche en sant du Qubec.


'/>"/>

Contact: Andrée-Anne Stewart
andree-anne.stewart@dc.ulaval.ca
418-656-3952
Universit Laval
Source:Eurekalert

Related medicine news :

1. Causes of serious pain syndrome closer to discovery
2. Cell division discovery could optimise timing of chemotherapy and explain some cancers
3. Major discovery on the mechanism of drug resistance in leukemia and other cancers
4. Discovery links rare, childhood neurodegenerative diseases to common problem in DNA repair
5. Discovery of anti-appetite molecule released by fiber could help tackle obesity
6. Brain cell discovery could open doors to targeted cancer therapies
7. LSTM-Eisai-UoL awarded GHIT Fund to deliver anti-Wolbachia drug discovery
8. Discovery sheds new light on marijuanas anxiety relief effects
9. Zebrafish discovery may shed light on human kidney function
10. NUS researchers make new discovery of protein as a promising target for treatment of ATC
11. Drug discovery potential of natural microbial genomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will present ... Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. ... Retina Group of New York , is a Board Certified ophthalmologist who completed ...
(Date:5/26/2016)... ... 26, 2016 , ... Leadership of Life Science Logistics (LSL), ... has earned its ISO 13485 certification, indicating the company’s quality control system for ... policies associated with ISO quality standard 13485. , BSI Group America, Inc., ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... be offering campers a multitude of activities from daily practices, arts & crafts, ... , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, ... the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led ... professional through the 8 hour interactive course to qualify participants as certified PowerWave ...
(Date:5/26/2016)... ... May 26, 2016 , ... A health conscious snack that doesn't sacrifice taste? ... has ignited an undeniable buzz in the protein product community by offering an alternative ... These doughnuts are packed with 11 grams of protein and made from a healthy ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today ... test for wounds and infections. This test ensures ... and select viruses. The test requires only a ... David G. Bostwick , MD, ... to facilitate wound healing: "We are excited to ...
(Date:5/24/2016)... Niederländische Chirurgen haben eine ... Ärzten erlaubt, ihre Expertise weltweit zu teilen und ... Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, in ... Europa, Afrika, Asien und den USA ... registriert. Information und Weiterbildung   ...
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
Breaking Medicine Technology: